SENEFFE, Belgium, September 18, 2013 /PRNewswire/ -- Eckert & Ziegler BEBIG announces its support of the brachytherapy program at Saint John Regional Hospital, Saint John, in the province of New Brunswick, Canada, which is part of the Horizon Health Network. The Adult Oncology Centre at Saint John Regional Hospital, employing five Radiation Oncologists and two Medical Oncologists, has been designated as a tertiary centre for Radiation Oncology and is at the forefront of multidisciplinary cancer care in the province. "Brachytherapy is an established technique commonly used as a boost in combination with other cancer therapies as well as a monotherapy. In the past, we had to send our patients to other hospitals to receive brachytherapy treatments. With our new high dose rate (HDR) brachytherapy program supported by Eckert & Ziegler BEBIG, we will be able to offer convenient access to an additional clinical option for our cancer patients." states Dr. Holly Campbell, Radiation Oncologist. The medical devices made available for the program by Eckert & Ziegler BEBIG included the state-of-the-art MultiSource® HDR afterloader. The system is in use in medical facilities in almost 40 countries worldwide and offers exclusive features like the fully integrated In-Vivo Dosimetry for real time dose monitoring. This feature along with the automatic catheter length measurement and the precise source position check underline the afterloader´s reputation of enabling for a high level of accuracy. Furthermore, the MultiSource® HDR afterloader runs with either an Iridium-192 or a particularly cost-effective Cobalt-60 source. Additionally, the Saint John Regional Hospital is using the treatment planning software HDRplus™ 3.0. The software supports all HDR applications, including intracavitary, interstitial, intraluminal as well as intraoperative treatments by offering a complete applicator database, automatic applicator reconstruction, automatic image fusion and the integrated Prostate Module.